What is it about?

This article explains the Jordanian Population Knowledge, Attitude and Practices on the Uses of Antidiabetics for Weight Loss, specifically, Ozempic, Saxenda and glucophage. Many of the users used without medical supervision and some of them got these medications from unauthorized suppliers.

Featured Image

Why is it important?

This is the first study to doxument public use of these GLP-1 Receptor Agonists in weight loss. People's interest in losing weight might put them at risk of receiving counterfeited formulations of these medications, especially, if they got it from unauthorized suppliers.

Read the Original

This page is a summary of: Knowledge, attitudes, and practices towards the use of GLP-1 receptor agonists for weight loss among the general population in Jordan; A cross-sectional study, PLOS One, December 2024, PLOS,
DOI: 10.1371/journal.pone.0314407.
You can read the full text:

Read
Open access logo

Contributors

The following have contributed to this page